Reuters -- Swiss drugs industry supplier Lonza (LONN.VX) is in talks to buy over 51 percent stake in India’s Aptuit Laurus in a deal valued at $77 million to $99 million, the Business Standard reported on Wednesday.
Reuters -- Swiss drugs industry supplier Lonza (LONN.VX) is in talks to buy over 51 percent stake in India’s Aptuit Laurus in a deal valued at $77 million to $99 million, the Business Standard reported on Wednesday.
